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Abstract
Background: Onychomycosis has a high prevalance among immunocompromised patients such
as diabetics and hemodialysis patients. In the present study, we aimed to investigate the prevalence
of onychomycosis among hemodialysis patients with and without diabetes mellitus, and to find out
the factors likely to be associated with the development of onychomycosis among hemodialysis
patients.
Methods: One hundred and nine hemodialysis patients were enrolled. Fifty-seven of hemodialysis
patients had the diagnosis of diabetes mellitus. Nail scrapings were obtained from 76 patients who
had dystrophic nail changes. Samples were examined with 20% potassium hydroxide solution and
all of the samples were inoculated on Saboraud's dextrose agar, potateus dextrose agar and
mycobiotic agar. Diagnosis of onychomycosis was based on the presence of both positive clinical
signs and positive potassium hydroxide test.
Results: Onychomycosis was diagnosed in 26.6% of hemodialysis patients. Diabetes mellitus was
present in 68.9% of patients with onychomycosis. Toenail scraping cultures were reported to be
positive in 19.7% of patients with dystrophic nail changes. Logistic regression analysis revealed that
the presence of diabetes mellitus and the mean duration of hemodialysis were the significant
predictors associated with the development of onychomycosis.
Conclusion: The prevalence of dystrophic nail changes and onychomycosis is increased among
hemodialysis patients. The dialysis duration and the presence of diabetes mellitus are the
independent risk factors associated with the development of onychomycosis in uraemic patients.
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Background
In general population, the prevalence of onychomycosis
(OM) ranged between 2 to 11.1% [1-4]. Risk factors asso-
ciated with the development of OM include increasing
age, immunosupression, the presence of diabetes melli-
tus, family history, peripheral vascular disease, and disor-
ders related to the skin such as hyperhidrosis, psoriasis,
onychogriposis and nail trauma [1,5-8].
Among diabetic patients, the reported prevalence of OM
ranges between 1.2–26% [9-11]. In a multicentre study,
the risk odds ratio for diabetic subjects to have toenail
onychomycosis has been reported as 2.77 times compared
with normal individuals [9]. Patients with chronic renal
failure may exhibit various cutaneous abnormalities
including pruritus, xerosis cutis, alterations in cutaneous
pigmentation, actinic elastosis and Raynaud's syndrome
[12]. Increased frequency of a spectrum of nail disorders
such as half-and-half nails, absence of lunula and splinter
hemorrhage are also reported to be increased in chronic
renal failure patients [13-15]. The frequency of OM in
hemodialysis (HD) patients has been shown to be higher
than healthy controls with a prevalence of 6.2–52%
[14,16]. In addition, onychomycosis has been reported to
be the second most frequent nail disorder in dialysis
patients [16].
Although increased prevalence of OM has been noted in
both patients with diabetes mellitus (DM) and patients
with chronic renal failure on hemodialysis, there is no
data related to the prevalence of OM among hemodialysis
patients with diabetes mellitus. Therefore, in the present
study, we aimed to investigate the prevalence of OM
among HD patients with and without DM, and to find out
the factors likely to be associated with the development of
toenail OM among HD patients.
Methods
Subjects
One hundred and nine (35 females and 74 males; mean
age: 54.6 ± 16.7) HD patients were enrolled in the study.
All HD subjects consisted of patients with end-stage renal
disease (ESRD) (creatinine clearance ≤ 5 mL/min/1.73
m2BS), who underwent HD treatment thrice weekly for 4
hours/day with blood flow rates of 200–250 mL/min and
dialysate flow rates of 480–500 mL/min using bicarbo-
nate dialysate on hollow-fiber artificial kidneys. The mean
dialysis duration was 2.8 ± 2.7 years. The etiology of end
stage renal failure were diabetic nephropathy in 36
patients (33%) and non-diabetic nephropathy in 73
patients (67%). Among patients who had non-diabetic
nephropathy, 21 patients have been diagnosed to have
diabetes mellitus according to American Diabetes Associ-
ation criteria revised in 2004 [17]. Eventually, a total of 57
study patients (52.3%) had the diagnosis of DM on the
time of the study.
The rate of treatment with insulin and oral hypoglycemic
agents among diabetic patients were 52.6% and 47.4%,
respectively. The study protocol was carried out in accord-
ance with the Helsinki Declaration as revised in 1989 and
approved by the Mustafa Kemal University Medical Fac-
ulty institutional review committee. All patients were
informed about the study protocol and the written con-
sent was obtained from each one.
Exclusion criteria
Exclusion criteria included the history of collagen vascular
disease, active infection, malignancy, alcohol abuse, cir-
rhosis, human immune deficiency virus infection, and the
usage of immunosuppressant.
Blood sample collection
Blood samples were drawn before a mid-week dialysis ses-
sion after an overnight fasting at 08:00 pm to determine
fasting blood glucose and glycosylated hemoglobin
(HbA1C) levels (Beckman-Coulter Synchron LX20 Clini-
cal. System; Beckman-Coulter, Fullerton, CA, USA).
Mycological evaluation
After a detailed examination of the fingers and toenails,
nail scrapings were obtained from 76 patients who exhib-
ited dystrophic nail changes. The mycological studies
included direct microscopic examination and culture. The
nails were cleaned using 70% ethanol before sampling.
Samples were obtained two times for each patient on dif-
ferent days. Microscopic examination of the nail scrapings
were performed with the use of 20% potassium hydroxide
(KOH) solution. Samples were cultured on Sabouraud
dextrose agar, potato dextrose agar and mycobiotic agar
(Sigma Chemical Co., St. Louis, Mo., USA). Cultures were
incubated at 26°C and examined twice a week for a total
duration of 4 weeks. The identification of dermatophytes
was based on their macroscopic examination of fungal
colonies and microscopic examination with lactophenol
cotton blue dye. Yeast species were identified using germ
tube test, selective agar CHROMagar Candida and API sys-
tem ID 32C (bioMerieux Marcy l'Etoile, France). Moulds
were considered as pathogens in the presence of following
findings;
-the absence of the other organisms growth at the same
culture media,
-the presence of mould growth at 3 samples,
-the presence of filaments identified at direct examina-
tion,BMC Infectious Diseases 2007, 7:102 http://www.biomedcentral.com/1471-2334/7/102
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-improvement with antifungal therapy.
The diagnosis of OM was based on the presence of both
positive clinical signs (dystrophic nail changes) and posi-
tive KOH test (OM positive group). Patients with negative
KOH test and patients who had no dystrophic nail
changes were grouped together as OM negative patients.
Statistical analyses
The SPSS for Windows 11.0 program (SPSS Inc, Chicago,
Illinois) was used for statistical analysis. A p value < 0.05
was considered statistically significant. Qualitative varia-
bles were assessed by Chi-square test. The multivariate
logistic regression analysis was used to determine the
association of independent variables such as age, gender,
duration of dialysis, diagnosis of DM, hemoglobin A1C
level, fasting blood glucose level, the presence of hyper-
tension, the type of antidiabetic and antihypertensive
medication, and the presence of diabetic nephropathy
with the development of OM.
Results
Dystrophic nail changes was observed in 46 (81%) dia-
betic and 30 (57.7%) non-diabetic HD patients p < 0.05).
OM was diagnosed in 29 (26.6%; OM positive group) out
of 109 HD patients according to the presence of both pos-
itive clinical signs (dystrophic nail changes) and positive
KOH test. OM negative group consisted of 80 patients.
DM was present in 20 (68.9%) patients of OM positive
group. Three out of 29 OM positive patients (10.3%) and
8 out of 80 OM negative patients (10%) had a positive
family history of OM (p > 0.05). None of the patients had
a history of nail trauma, tight and high heeled or trau-
matic shoes, and excessive sweating of foot during activ-
ity.
Toenail scraping cultures were reported to be positive in
15 (%19.7) out of 76 patients who exhibited dystrophic
nail changes. In 13 culture positive patients, the isolated
fungi were dermatophyte and non-dermatophyte in 13
(86.7%) and 2 (13.3%), respectively (Table 1).
Logistic regression analysis revealed that the presence of
DM and the mean duration of hemodialysis were the sig-
nificant predictors associated with the development of
OM (Table 2). The predicted probabilities of the develop-
ment of OM according to the duration of dialysis were
plotted in diabetic and non-diabetic subjects (Figure 1).
The other independent variables such as age, gender,
hemoglobin A1C level, fasting blood glucose level, the
presence of hypertension, the type of antidiabetic and
antihypertensive medication, and the presence of diabetic
nephropathy were not correlated with the development of
OM (all p > 0.05).
Discussion
In the present study, in concordance with the previous
reports [13,14,18,19], we showed that the prevalence of
abnormal appearing toenails and OM were increased
among HD patients. In addition, HD patients with DM
had higher dystrophic nail changes and OM prevalence
compared to HD patients without DM. However, as the
prevalence of dystrophic nail changes and OM prevalence
among HD patients with DM have not been previously
reported, we could not compare our findings with the lit-
erature findings.
In HD patients, increased susceptibility to nail disorders
and OM may be due to both impaired immunity and his-
tological changes of the skin caused by uremia. Histolog-
ical alterations of the skin in uremic patients include
severe microangiopathy and pericollogenous deposition
of amyloid, identified as beta 2-microglobulin amyloido-
sis [20,21]. In venules and arterioles, endothelial cell acti-
vation and/or necrosis, basement membrane zone
thickening and reduplication of basal lamina was also
noted [22].
Previous studies have demonstrated that the prevalance of
nail disease increased with HD duration [16,18]. Further-
more, Saray et al. demonstrated a possible relationship
between HD duration and prevalance of OM among HD
patients [19]. In concordance with those reports, in the
present study, we observed that dialysis duration was an
independent risk factor associated with the development
of OM.
Predicted probability of onychomycosis according to dura- tion of dialysis in the diabetic and nondiabetic patients Figure 1
Predicted probability of onychomycosis according to dura-
tion of dialysis in the diabetic and nondiabetic patients.BMC Infectious Diseases 2007, 7:102 http://www.biomedcentral.com/1471-2334/7/102
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In comparison with the general population, patients with
DM are predisposed to mycotic infections such as
mucormycosis, and Candida infection of the mucous
membranes, nails and skin folds [23]. Besides the high
blood glucose levels and impaired immunity, diabetes
related medical conditions may also provide contribution
to the development of OM in diabetic patients [24]. For
example, peripheral vascular disease results in impaired
wound healing and increased risk of infection, and
peripheral neuropathy results in decreased ability to
detect the presence and the progression of infection [25].
Although conflicting reports [26,27] are available,
patients with DM have been reported to prone to dermat-
ophyte infections [28,29]. In addition, in two recent large
scale studies [9,11], the prevalence of OM has been shown
to be significantly higher in diabetic patients than normal
individuals and increasing age, male gender, family his-
tory of onychomycosis, concurrent intake of immunosup-
pressive agents and peripheral vascular disease have been
shown as independent risk factors for the development of
OM. In contrast, in the present study, we did not find any
correlation of increasing age, male gender, and family his-
tory of onychomycosis with the development of OM. This
difference may be, in part, due to distinct characteristics of
our patients (uremia plus DM). As we excluded patients
receiving immunosuppressive agents and we did not
investigate the presence of peripheral vascular disease in
our patients, we could not make a comparison regarding
to the influence of those parameters on the development
of OM.
In the present study, Trichophyton rubrum was the most fre-
quently isolated organism from the cultures and it was fol-
lowed by T. mentagrophytes. These findings were in
concordance with the previous studies conducted in dia-
betics without renal disease and normal population
[9,10]. Interestingly, in the present study, Pichia etchellsii/
carsonii, a non-pathogen yeast fungi, was isolated in one
HD patients with DM. Although it may be an incidental
colonization (not an infection) of toenail, it should be
kept in mind that this non-pathogen yeast may become a
potential pathogen in the presence of immunosupression
caused by both DM and uremia.
Conclusion
The prevalence of dystrophic nail changes and OM is
increased among HD patients. The dialysis duration and
the presence of DM are the independent risk factors asso-
ciated with the development OM in uremia patients. As
fungal infections have a potential progressive nature and
dangerous serious outcome including erysipelas and in
long term even amputation, especially HD patients with
diabetes mellitus should be periodically examined for
OM. In addition, education of the diabetic hemodialysis
patients about the importance of foot and nail care should
be an essential components in the management of those
patients.
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Table 1: The frequency of isolated fungi toenail scraping cultures
Isolated fungi Number of 
cultures
Type of fungi Positive cultures 
(%)
KOH (+) patients 
(%)
Patients with DNC 
(%)
T. rubrum 10 (9.2%) D 51.7 34.5 13.2
T. mentagrophytes 2 (1.8%) D 13.3 6.9 2.6
Epidermophyton 
floccosum
1 (0.9%) D 6.6 3.4 1.3
Aspergillus niger 1 (0.9%) ND 6.6 3.4 1.3
Pichia etchellsii/carsonii 1 (0.9%) ND 6.6 3.4 1.3
Contamination 3 (2.8%) - - 10.3 3.9
Negative 58 (53.2%) - - - 76.3
T, Trichophyton; D, Dermatophyte; ND, Non-dermatophyte; KOH, potassium hydroxide; DNC, Dystrophic nail changes.
Table 2: Logistic regression analysis determining the significant 
predictors of the development of onychomycosis
Variable Significance 
(p)
Relative risk 95% CI
Diabetes 
mellitus
0.009 4.0232 1.417–11.424
Duration of 
dialysis 
(years)
0.008 1.2499 1.059–1.475
CI, confidence interval.
Logit (OM) = -2.52 + 1.39 (Diabetes) + 0.223 (Duration of dialysis)Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Infectious Diseases 2007, 7:102 http://www.biomedcentral.com/1471-2334/7/102
Page 5 of 5
(page number not for citation purposes)
Authors' contributions
GK, MC, GG, MH: Conception and design; MD, CA, SS,
HK: Analysis and interpretation of the data; GG, GK, MD,
HK: Drafting of the article; MC, MH, CA, SS, HK, AAK:
Critical revision of the article for important intellectual
content; GG, GK, MD, HK: provision of study materials or
patients; GG, GK: Statistical expertise; GK, MC, MD, CA,
SS: Collection and assembly of data. All authors read and
approved the final manuscript.
References
1. Sigurgeirsson B, Steingrimsson O: Risk factors associated with
onychomycosis.  J Eur Acad Dermatol Venereol 2004, 18:48-51.
2. Sigurgeirsson B, Steingrimsson O, Sveinsdottir S: Prevalance of
onychomycosis in Iceland: a poulation based study.  Acta Derm
Venereol 2002, 82:467-469.
3. Heikkila H, Stubb S: The prevalance of onychomycosis in Fin-
land.  Br J Dermatol 1995, 133:699-703.
4. Roberts DT: Prevalance of dermatophyte onychomycosis in
United Kingdom: results of an omnibus survey.  Br J Dermato
1992, 126:23-27.
5. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordin-
sky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker
DC, Buttler B, Lowery BJ: Guidelines of care for superficial
mycotic infections of the skin: onychomycosis.  J Am Acad Der-
matol 1996, 34:116-121.
6. Elewski BE, Charif MA: Prevalance of onychomycosis in patients
attending a dermatology clinic in northeastern Ohio for
other conditions.  Arch Dermatol 1997, 133:1317-1318.
7. Scher RK: Onychomycosis: a significant medical disorder.  J Am
Acad Dermatol 1996, 35:2-5.
8. Cohen JL, Scher RK, Pappert AS: The nail and fungus infections.
In Cutaneous fungal infections Edited by: Elewski B. New York: Igaku-
Shoin Inc; 1992:106-122. 
9. Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds
MW, McManus R, Summerbell RC: Prevalance and epidemiology
of toenail onychomycosis in diabetic subjects: a multicentre
study.  Br J Dermatol 1998, 139:665-671.
10. Romano C, Massai L, Asta F, Signorini AM: Prevalance of dermat-
ophtic skin and nail infections in diabetic patients.  Mycosis
2001, 44:83-86.
11. Dogra S, Kumar B, Bhansali A, Chakrabarty A: Epidemiology of
onychomycosis in patients with diabetes mellitus in India.  Int
J Dermatol 2002, 41:647-651.
12. Avermaete A, Altmeyer P, Bacharach-Buhles M: Skin changes in
dialysis patients: a review.  Nephrol Dial Transplant 2001,
16:2293-2296.
13. Bencini PL, Montagnino G, Citterio A, Graziani G, Crosti C, Ponticelli
C: Cutaneous abnormalities in uremic patients.  Nephron 1985,
40:316-321.
14. Pico MR, Lugo-Somolinos A, Sanchez JL, Burgos-Calderon R: Cuta-
neous alterations in patients with chronic renal failure.  Int J
Dermatol 1992, 31:860-863.
15. Kint A, Bussels L, Fernandes M, Ringoir S: Skin and nail disorders
in relation to chronic renal failure.  Acta Derm Venereol (Stock-
holm) 1974, 54:137-140.
16. Tercedor J, Lopez Hemandez B, Manuel rodenas J: Nail diseases in
haemodialysis patients: case-control study.  Br J Dermatol 2001,
144:445-446.
17. American Diabetes association: Diagnosis and Classification of
Diabetes Mellitus.  Diabetes Care 2004, 27:10-15.
18. Altmeyer P, Kachel HG, Junger M, Koch KM, Holzmann H: Skin
changes in long term dialysis patients. Clinical study.  Hautarzt
1982, 33:137-142.
19. Saray Y, Seckin D, Güleç AT, Akgün S, Haberal M: Nail disorders in
hemodialysis patients and ranal transplant recipients: A
case-control study.  J Am Acad Dermatol 2004, 50:197-202.
20. Gilchrest BA, Rowe JW, Mihm MC: Clinical and histological skin
changes in chronic renal failure: evidence for a dialysis-resist-
ant, transplant-responsive microangiopathy.  Lancet 1980,
2:1271-1275.
21. Altmeyer P, Kachel HG, Runne U: Microangiopathy, connective
tissue changes and amyloid deposits in chronic renal failure.
Hautarzt 1983, 34:277-283.
22. Lundin AP, Fani K, Berlyne GM, Friedman EA: Dermal angiopathy
in hemodialysis patients: the effect of the time.  Kidney Int
1995, 47:1775-1780.
23. Freinkel RK, Freinkel N: Dermatologic manifestations of endo-
crine disorders.  In Dermatology in Medicine Volume 199. 5th edition.
Edited by: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen
KF. New York: McGraw-Hill :1162-1163. 
24. Gupta AK, Humke S: The prevalance and management of ony-
chomycosis in diabetic patients.  European Journal of Dermatology
2000, 10:379-384.
25. Rich P, Hare A: Onychomycosis in a special patient population:
focus on diabetic.  Int J Dermatol 1999, 38:17-19.
26. Lugo-Somolinos A, Sanchez JL: Prevalance of dermatophytosis in
patients with diabetes.  J Am Acad Dermatol 1992, 26:408-410.
27. Buxton PK, Milne LJR, Prescott RJ, Proudfoots MC, Stuart FM: The
prevalance of dermatophyte infection in well-controlled dia-
betics and the response to Trichophyton antigen.  Br J Derma-
tol 1996, 134:900-903.
28. Jolly HW, Carpenter CLJ: Oral glucose tolerance studies in
recurrent Trichophyton rubrum infections.  Arch Dermatol
1969, 100:26-28.
29. Alteras I, Saryt E: Prevalance of pathogenic fungi in the
toewebs and toenails of diabetic patients.  Mychopathologia
1979, 67:26-28.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/7/102/pre
pub